Covered recipient · General Payments record

MICHAEL T OGAWA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI: 1477896538
CMS profile: 1397616
Location: CHESTERFIELD, MO

General Payments · PY2018–2024

$2,906.79

Reported across 131 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,006.17

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,006.17	53

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
NOVARTIS PHARMACEUTICALS CORPORATION	$234.11	11
Celgene Corporation	$128.67	7
Acerta Pharma LLC	$91.44	5
PFIZER INC.	$81.68	5
E.R. Squibb & Sons, L.L.C.	$68.97	4
Daiichi Sankyo Inc.	$51.23	3
EISAI INC.	$48.53	2
Karyopharm Therapeutics Inc.	$26.81	1
EMD Serono, Inc.	$25.07	1
Regeneron Healthcare Solutions, Inc.	$24.06	1
ABBVIE INC.	$23.83	1
Gilead Sciences, Inc.	$21.28	1
JAZZ PHARMACEUTICALS INC.	$21.19	1
Janssen Biotech, Inc.	$21.17	1
SOBI, INC	$21.07	1
Fennec Pharmaceuticals, Inc.	$20.04	2
Coherus Biosciences Inc.	$19.03	1
Incyte Corporation	$17.99	1
Takeda Pharmaceuticals U.S.A., Inc.	$17.39	1
PUMA BIOTECHNOLOGY, INC.	$14.94	1
Astellas Pharma US Inc	$14.32	1
Genentech USA, Inc.	$13.35	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$772.23	34
PY2019	$179.53	6
PY2020	$40.18	3
PY2022	$12.02	1
PY2023	$896.66	34
PY2024	$1,006.17	53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$23.83	10/10/2024	Food and Beverage	Undisputed	01/23/2026	1105147008	CMS
Astellas Pharma US Inc	$14.32	03/14/2024	Food and Beverage	Undisputed	01/23/2026	1139294912	CMS
AstraZeneca Pharmaceuticals LP	$14.06	01/05/2024	Food and Beverage	Undisputed	01/23/2026	1105815975	CMS
AstraZeneca Pharmaceuticals LP	$20.71	03/22/2024	Food and Beverage	Undisputed	01/23/2026	1104615894	CMS
AstraZeneca Pharmaceuticals LP	$19.84	05/02/2024	Food and Beverage	Undisputed	01/23/2026	1104435383	CMS
AstraZeneca Pharmaceuticals LP	$16.45	05/08/2024	Food and Beverage	Undisputed	01/23/2026	1104598646	CMS
AstraZeneca Pharmaceuticals LP	$20.38	05/18/2024	Food and Beverage	Undisputed	01/23/2026	1104398691	CMS
Celgene Corporation	$15.07	01/11/2024	Food and Beverage	Undisputed	01/23/2026	1101156308	CMS
Celgene Corporation	$15.91	05/03/2024	Food and Beverage	Undisputed	01/23/2026	1101156322	CMS
Celgene Corporation	$21.85	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1101156324	CMS
Celgene Corporation	$16.85	08/27/2024	Food and Beverage	Undisputed	01/23/2026	1101156326	CMS
Celgene Corporation	$19.64	09/20/2024	Food and Beverage	Undisputed	01/23/2026	1101156330	CMS
Celgene Corporation	$19.69	10/24/2024	Food and Beverage	Undisputed	01/23/2026	1101156336	CMS
Celgene Corporation	$19.66	11/04/2024	Food and Beverage	Undisputed	01/23/2026	1101156338	CMS
Coherus Biosciences Inc.	$19.03	02/02/2024	Food and Beverage	Undisputed	01/23/2026	1147277582	CMS
Daiichi Sankyo Inc.	$19.81	01/30/2024	Food and Beverage	Undisputed	01/23/2026	1089464030	CMS
Daiichi Sankyo Inc.	$13.19	03/25/2024	Food and Beverage	Undisputed	01/23/2026	1089464028	CMS
Daiichi Sankyo Inc.	$18.23	05/09/2024	Food and Beverage	Undisputed	01/23/2026	1089464032	CMS
E.R. Squibb & Sons, L.L.C.	$15.30	04/16/2024	Food and Beverage	Undisputed	01/23/2026	1101566061	CMS
E.R. Squibb & Sons, L.L.C.	$14.95	08/15/2024	Food and Beverage	Undisputed	01/23/2026	1101566091	CMS
E.R. Squibb & Sons, L.L.C.	$16.24	09/19/2024	Food and Beverage	Undisputed	01/23/2026	1101566102	CMS
E.R. Squibb & Sons, L.L.C.	$22.48	10/03/2024	Food and Beverage	Undisputed	01/23/2026	1101566110	CMS
Eisai Inc.	$24.73	01/19/2024	Food and Beverage	Undisputed	01/23/2026	1110766179	CMS
Eisai Inc.	$23.80	08/08/2024	Food and Beverage	Undisputed	01/23/2026	1110766177	CMS
EMD Serono, Inc.	$25.07	06/13/2024	Food and Beverage	Undisputed	01/23/2026	1120236390	CMS
Fennec Pharmaceuticals, Inc.	$8.19	01/15/2024	Food and Beverage	Undisputed	01/23/2026	1120186084	CMS
Fennec Pharmaceuticals, Inc.	$11.85	03/01/2024	Food and Beverage	Undisputed	01/23/2026	1120186082	CMS
Genentech USA, Inc.	$13.35	10/11/2024	Food and Beverage	Undisputed	01/23/2026	1133070837	CMS
Gilead Sciences, Inc.	$21.28	06/03/2024	Food and Beverage	Undisputed	01/23/2026	1133801072	CMS
Incyte Corporation	$17.99	12/13/2024	Food and Beverage	Undisputed	01/23/2026	1141174313	CMS
Janssen Biotech, Inc.	$21.17	06/14/2024	Food and Beverage	Undisputed	01/23/2026	1078781423	CMS
JAZZ PHARMACEUTICALS INC.	$21.19	11/26/2024	Food and Beverage	Undisputed	01/23/2026	1150217405	CMS
Karyopharm Therapeutics Inc.	$26.81	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1145533716	CMS
Novartis Pharmaceuticals Corporation	$23.44	04/09/2024	Food and Beverage	Undisputed	01/23/2026	1087174357	CMS
Novartis Pharmaceuticals Corporation	$20.08	04/11/2024	Food and Beverage	Undisputed	01/23/2026	1087174355	CMS
Novartis Pharmaceuticals Corporation	$21.92	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1087174359	CMS
Novartis Pharmaceuticals Corporation	$16.03	04/25/2024	Food and Beverage	Undisputed	01/23/2026	1087174361	CMS
Novartis Pharmaceuticals Corporation	$18.02	08/02/2024	Food and Beverage	Undisputed	01/23/2026	1087174371	CMS
Novartis Pharmaceuticals Corporation	$23.11	08/16/2024	Food and Beverage	Undisputed	01/23/2026	1087174373	CMS
Novartis Pharmaceuticals Corporation	$26.41	08/29/2024	Food and Beverage	Undisputed	01/23/2026	1087174379	CMS
Novartis Pharmaceuticals Corporation	$25.24	09/17/2024	Food and Beverage	Undisputed	01/23/2026	1087174381	CMS
Novartis Pharmaceuticals Corporation	$19.31	10/31/2024	Food and Beverage	Undisputed	01/23/2026	1087174383	CMS
Novartis Pharmaceuticals Corporation	$21.54	11/08/2024	Food and Beverage	Undisputed	01/23/2026	1087174385	CMS
Novartis Pharmaceuticals Corporation	$19.01	12/03/2024	Food and Beverage	Undisputed	01/23/2026	1087174387	CMS
PFIZER INC.	$16.55	01/09/2024	Food and Beverage	Undisputed	01/23/2026	1131091928	CMS
PFIZER INC.	$13.25	03/07/2024	Food and Beverage	Undisputed	01/23/2026	1131298393	CMS
PFIZER INC.	$16.98	06/22/2024	Food and Beverage	Undisputed	01/23/2026	1131699553	CMS
PFIZER INC.	$16.19	08/09/2024	Food and Beverage	Undisputed	01/23/2026	1131369187	CMS
PFIZER INC.	$18.71	09/13/2024	Food and Beverage	Undisputed	01/23/2026	1131904117	CMS
PUMA BIOTECHNOLOGY, INC.	$14.94	05/14/2024	Food and Beverage	Undisputed	01/23/2026	1113842873	CMS
Regeneron Healthcare Solutions, Inc.	$24.06	03/08/2024	Food and Beverage	Undisputed	01/23/2026	1114127194	CMS
SOBI, INC	$21.07	01/25/2024	Food and Beverage	Undisputed	01/23/2026	1141416148	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$17.39	03/28/2024	Food and Beverage	Undisputed	01/23/2026	1144964320	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.